<?xml version="1.0" encoding="UTF-8"?>
<p>To date, FDA-licensed vaccines and antivirals are the most effective methods available to prevent and/or control influenza viral infections. However, influenza vaccines require at least 2 weeks after administration to induce protective immune responses against viral infection. In the case of antivirals, their effectiveness is dependent on being administered within 48 h after the appearance of symptoms [
 <xref rid="B58-viruses-12-00167" ref-type="bibr">58</xref>,
 <xref rid="B59-viruses-12-00167" ref-type="bibr">59</xref>]. Importantly, antiviral-resistant strains have been described [
 <xref rid="B1-viruses-12-00167" ref-type="bibr">1</xref>,
 <xref rid="B23-viruses-12-00167" ref-type="bibr">23</xref>,
 <xref rid="B24-viruses-12-00167" ref-type="bibr">24</xref>,
 <xref rid="B25-viruses-12-00167" ref-type="bibr">25</xref>]. Consequently, these prevention and treatment methods still leave substantial public health vulnerabilities.
</p>
